ORIGINAL RESEARCH article
Front. Nutr.
Sec. Food Chemistry
Volume 12 - 2025 | doi: 10.3389/fnut.2025.1674507
Quercetin reverses β1-adrenoceptor autoantibody-induced heart 1 failure by promoting MDM2-mediated ubiquitination and 2 degradation of p53 in cardiomyocytes
Provisionally accepted- Shanxi Medical University, Taiyuan, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Introduction: Cardiomyocyte autophagy is essential for preserving cardiac 24 homeostasis. Previous studies revealed that β1-adrenergic receptor autoantibody 25 (β1-AA) suppressed cardiomyocyte autophagy, triggering cell death and heart failure 26 (HF). Qiliqiangxin capsule enhances autophagy and mitigates HF through multiple 27 pathways, but its complex composition complicates mechanistic clarity. Network 28 pharmacology identified quercetin as a pivotal autophagy-inducing component in 29 Qiliqiangxin, yet its role in counteracting β1-AA-induced autophagy impairment 30 remains unvalidated. In this study quercetin's therapeutic potential and mechanisms in 31 restoring autophagy in β1-AA-associated HF. 32 Methods: Bioinformatics methods, including a STRING database analysis, PPI 33 network construction, and Cytoscape-based pathway mapping, were used to delineate 34 quercetin's autophagy-related targets. The in vivo efficacy was assessed in 35 β1-AA-positive mice treated with quercetin (100 mg/[kg·d], intraperitoneal). The in 36 vitro validation used H9c2 cardiomyocytes pretreated with quercetin (100 μM) prior 37 to β1-AA exposure. Autophagy markers, p53 signaling, and ubiquitination pathways 38 were analyzed by immunoblotting and functional enrichment analysis using the 39 GOrilla database. A p53 knockdown and overexpressing cardiomyocyte model 40 confirmed pathway specificity. 41 Results: Quercetin administration significantly restored myocardial autophagy levels 42 in β1-AA-positive mice, which improved cardiac function and survival rates. In H9c2 43 cells, quercetin pretreatment reversed β1-AA-induced autophagy suppression. 44 Bioinformatics linked quercetin to p53 pathway modulation, with experimental 45 validation showing quercetin downregulated p53 expression via MDM2-mediated 46 ubiquitination. p53 knockdown enhanced autophagy, while its overexpression blocked 47 quercetin's effect, indicating quercetin restores autophagy in a p53-dependent manner. 48 GO enrichment highlighted the association between quercetin and 49 ubiquitin-dependent protein degradation, which was corroborated by elevated MDM2 50 levels and accelerated p53 degradation in quercetin-treated cells. 51 字体: (默认)Times New Roman Italic, 倾斜 设置格式[Mingxia Ma]: 3 Discussion: Quercetin rescues β1-AA-impaired cardiomyocyte autophagy by 52 activating MDM2-dependent p53 ubiquitination and degradation, thereby attenuating 53 HF progression. These findings establish quercetin as a mechanistic basis of the 54 cardioprotective effects of Qiliqiangxin and provide preclinical evidence for targeting 55 autophagy by regulating p53 in β1-AA-induced cardiac dysfunction.
Keywords: Heart Failure, β1-adrenoceptor autoantibody, Autophagy, Ubiquitination, Quercetin
Received: 28 Jul 2025; Accepted: 29 Sep 2025.
Copyright: © 2025 Ma, Jiang, Liu, Xue, Yuan, Zhi, Feng, Long, Li, Zhang, Wang and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Li Wang, mirror0117@126.com
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.